December 10, 2014

Basic Research: Tracking Down the Causes of Ciliopathies

Useful zebrafish model drives progress

cole eye zebra fish study

The laboratory of ophthalmic researcher Brian Perkins, PhD, at Cleveland Clinic’s Cole Eye Institute is on a mission to find out what happens at the molecular and cellular levels when genetic mutations cause ciliopathies – multi-syndrome diseases that affect cilia, structures found in all cells but which are critically important for survival of rod and cone photoreceptors in the eye.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ophthalmology Block Text Link to :

“We try to understand how different genetic mutations contribute to the severity of blindness in children, and whether multiple genes increase or decrease the effects,” he says.

Along with other methods, Dr. Perkins and his colleagues use zebrafish as an animal model to examine how mutations affect the structure of rods and cones, as well as whether the mutations affect the cellular function of other proteins.

According to Dr. Perkins, the zebrafish is a small, freshwater fish with eyes that are remarkably similar to those of humans. “We have zebrafish that carry mutations in the same genes that cause multiple ciliopathies in humans, including Joubert Syndrome, and the fish often have very similar defects,” he says.

Joubert Syndrome is a rare but debilitating disease that causes neurological problems, varying degrees of mental retardation or developmental delays, kidney cysts, and often, progressive retinal degeneration.

According to Dr. Perkins, mutations in several different genes cause the disease, and this contributes to a wide degree of clinical variability and difficulty in making prognoses.


Although understanding of Joubert disease and other ciliopathies has greatly improved over the past decade, current knowledge is still somewhat limited on what these genes do at the cellular level and how mutations disrupt their function.

The genetic underpinnings of the disease have been identified, but there’s still no clear picture on the role of encoded proteins at the molecular level.

One challenge the researchers face is in understanding the different requirements of genes for rod and cone photoreceptors versus those for kidney or brain cells. Another challenge is to determine how the underlying genetics influences clinical variability.

Dr. Perkins and his colleagues bring an array of knowledge to bear on these challenges, including a background in genetics and molecular biology. Histological and microscopy techniques also help researchers understand how genetic mutations affect the structure of the zebrafish retina.

Cutting-edge techniques include the creation of transgenic zebrafish to detect certain proteins or generate specific mutations that correspond to known human genetic mutations.


The researchers collaborate with clinicians and other scientists at the Cole Eye Institute when they identify new mutations in patients with ciliopathies.

Perhaps the zebrafish model is the most important tool researchers have. “Zebrafish are small and inexpensive. Combined with the broad array of genetic tools at our disposal, they make it possible to address many questions more easily and quickly than with other model systems,” Dr. Perkins says.

Today his lab’s work remains at the basic science level. In the short term, the goal is to give genetic counselors a more complete understanding of whether certain mutations lead to photoreceptor loss and blindness.

In the long term, Dr. Perkins intends to clarify the genetic landscape of the disease to better enable future treatments so that they are more appropriate and personalized for each patient.

Related Articles

September 19, 2023
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

August 14, 2023
Don’t Believe Everything Chatbots Say About Ophthalmic Research

30% of references generated by ChatGPT don’t exist, according to one study

22-EYE-3391159 CQD-Treating Retinoschisis-hero
December 23, 2022
Long-Term Topical Dorzolamide Improves Visual Acuity in Juvenile X-Linked Retinoschisis

Study followed patients an average of eight years

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero
September 7, 2022
Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD
August 23, 2022
DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

22-EYE-3049477 New findings in retinal regeneration-Perkins-650×450-4
August 3, 2022
Restoring the Retina: How to Regenerate Photoreceptors in Inherited Retinal Dystrophy

Notch pathway inhibition preserves retinal neurons and promotes regrowth in zebrafish

22-EYE-2952199 CQD-Fixation eye movement abnormalities in amblyopia-Ghasia-650×450
July 29, 2022
Amblyopia: Eye Movement Recordings Enhance Understanding of Visual Deficits

Patients frequently have problems with depth perception and interocular suppression

A Cleveland Clinic Cole Eye Institute ophthalmologist uses intraoperative OCT during retinal surgery.
June 24, 2022
3D Viewing System Improves Surgical-Field-Based Visualization of iOCT Data

Surgeons also report benefits of integrated heads-up display